Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come

DSpace/Manakin Repository

Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come

Citable link to this page

 

 
Title: Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come
Author: Stahl, Andreas; Hellstrom, Ann; Smith, Lois Elaine Hodgson

Note: Order does not necessarily reflect citation order of authors.

Citation: Stahl, Andreas, Ann Hellstrom, and Lois E.H. Smith. 2014. Insulin-Like Growth Factor-1 and Anti-Vascular Endothelial Growth Factor in Retinopathy of Prematurity: Has the Time Come. Neonatology 106, no. 3: 254–260. doi:10.1159/000365132.
Full Text & Related Files:
Abstract: Treatment of ROP is currently evolving. Novel therapeutic options are emerging that have the potential to complement existing therapies and improve treatment outcomes. However, any new therapeutic options must be thoroughly evaluated before existing (and successful) treatment paradigms can be amended. This is particularly so when switching from locally effective therapies like photablative laser therapy to systemic pharmacologic treatments that may have hitherto unknown widespread side effects. This review compiles the current knowledge of where and when the two most advanced pharmacologic treatment options for ROP, IGF-1 supplementation and anti-VEGF treatment, may have their place in future therapy regimens for ROP. The requirement for clinical studies is emphasized: these are needed to address safety considerations before any of these interventions can achieve the status of standard clinical care in the very vulnerable population of ROP infants.
Published Version: doi:10.1159/000365132
Other Sources: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197141/
Terms of Use: This article is made available under the terms and conditions applicable to Open Access Policy Articles, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#OAP
Citable link to this page: http://nrs.harvard.edu/urn-3:HUL.InstRepos:33776188
Downloads of this work:

Show full Dublin Core record

This item appears in the following Collection(s)

 
 

Search DASH


Advanced Search
 
 

Submitters